Physician profile
Jon R Mattson
NPI 1346253580
$53,405.35
in general payments reported to CMS, 2019-2025
17 companies · $637 in 2025
The $637 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $2,741 · 2021: $5,589 · 2022: $9,443 · 2023: $19K · 2024: $1,512 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Travel and Lodging: $3,370 · Consulting Fee: $3,200 · Food and Beverage: $1,499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,260.00 |
| Travel and Lodging | $3,369.89 |
| Consulting Fee | $3,200.00 |
| Food and Beverage | $1,498.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $51,842.90 | 2019-2025 | Puraply, Apligraf, Puraply Antimicrobial |
| Mallinckrodt Hospital Products INC. | $228.89 | 2022-2025 | Acthar |
| Coloplast Corp | $205.95 | 2021 | |
| Hydrofera LLC | $156.81 | 2022-2025 | Hydrofera Blue |
| Musculoskeletal Transplant Foundation INC. | $148.74 | 2019 | |
| Horizon Therapeutics Plc | $135.47 | 2019 | |
| Integra Lifesciences Corporation | $120.92 | 2019 | |
| Convatec INC. | $117.74 | 2021 | |
| Melinta Therapeutics, LLC | $114.33 | 2022 | |
| Amgen INC. | $86.22 | 2024-2025 | Uplizna, Krystexxa |
| Alexion Pharmaceuticals, INC. | $68.88 | 2024 | Strensiq |
| Lilly USA, LLC | $45.43 | 2019 | |
| Novartis Pharmaceuticals Corporation | $42.25 | 2022 | |
| Abbvie INC. | $29.05 | 2022 | |
| Mimedx Group, INC. | $25.12 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgenex LLC | $23.37 | 2025 | Surgraft, Ardeograft, Pellograft |
| Osiris Therapeutics INC. | $13.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Mattson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.